Related Experiment Video
Updated: Jun 21, 2026

A Recovery Cardiopulmonary Bypass Model Without Transfusion or Inotropic Agents in Rats
Published on: March 23, 2018
Heparin resistance during cardiopulmonary bypass
Hyun Ju Jung1, Jong Bun Kim, Kyong Shil Im
1Department of Anesthesiology and Pain Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea.
Abstract:
The hemostatic system is activated during cardiopulmonary bypass (CPB) procedures, and the use of heparin attenuates the coagulation. However, heparin resistance occurs in between 4 and 22% of patients undergoing cardiac surgery, and the preoperative use of heparin is usually responsible for this. Sometimes, critically ill patients are referred for intra-aortic balloon pump (IABP) insertion, and anticoagulation therapy with heparin is recommended to prevent thrombosis and embolization. The author experienced heparin resistance in patients who underwent percutaneous coronary intervention (PCI) and IABP insertion.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiac Catheterization II: Right Heart Catheterization
Pulmonary Embolism I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Depolarizing Blockers: Pharmocokinetics

